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ABSTRACT
Vectors used for gene targeting experiments usually
consist of a selectable marker flanked by two regions
of homology to the targeted gene. In a homologous
recombination event, the selectable marker replaces
an essential element of the target gene rendering
it inactive. Other applications of gene targeting
technology include gene replacement (knockins)
and conditional vectors which allow for the genera-
tion of inducible or tissue-specific gene-targeting
events. The assembly of gene-targeting vectors
is generally a laborious process requiring consider-
able technical skill. The procedures presented here
report the application of transposons as tools for
the construction of targeting vectors. Two mini-Mu
transposons were sequentially inserted by in vitro
transposition at each side of the region targeted for
deletion. One such transposon carries an antibiotic
resistancemarkersuitableforselectioninmammalian
cells. A deletion is then generated between the two
transposons either by LoxP-induced recombination
or by restriction digestion followed by ligation. This
deletion removes part of both transposons plus
the targeted region in between, leaving a transposon
carrying the selectable marker flanked by two
arms which are homologous to the targeted gene.
Targeting vectors constructed using these trans-
posons were electroporated into embryonic stem
cells and shown to be effective in gene-targeting
events.
INTRODUCTION
A ‘gene knockout’ refers to the targeted inactivation of a
gene in a cell or an organism. The technology relies on the
replacement of the wild-type gene on a chromosome (the
target gene) by an inactivated gene on a targeting vector by
homologous recombination. The targeting vector generally
contains a selectable marker such as the neomycin resistance
(Neo
r) gene ﬂanked by two homology arms. The conventional
way of constructing a targeting vector consists of multiple
cloning steps, some of which involve the manipulation of
large fragments which are frequently susceptible to DNA
rearrangements. This makes the construction process technic-
ally demanding and time consuming.
To overcome these issues we developed a series of
transposons which allow the random insertion of both
selectable markers and restriction (or recombination) sites.
Transposons are discrete DNA segments able to undergo
random insertion events, a process referred to as transposition
[for recent reviews, see (1–4)]. Such elements are present
in both prokaryotes and eukaryotes. Bacterial transposons
have been studied in detail and used widely in molecular
biology. For example, some of them have been inserted
into eukaryotic genes as well as bacterial genes for the purpose
of insertional mutagenesis (5–11). They have also been
utilized as a tool to insert primer-binding sites for sequencing
(5,9,12). The mechanisms and modes of transposition vary
for different transposons (1,13). Generally, transposition
involves the recognition of the transposon ends by the
transposon-encoded transposase(s), followed by recombina-
tion events between the transposon ends and the site of inser-
tion. A number of in vitro transposon systems have been
developed, where one or more puriﬁed transposase(s) catalyse
the transposition of a mini-transposon to a recipient DNA
molecule (14–20). In such systems, generally, the transpo-
sase(s) alone is sufﬁcient and no accessory protein and
DNA cofactors are required.
The current study reports a generic system for the genera-
tion of classical targeting vectors that can be used in any
species, using bacteriophage Mu-based transposons. An added
beneﬁt of this system is that most steps of the process may be
automated allowing for the high-throughput generation of
targeting vectors.
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PCR, DNA manipulation and cloning
PCR was carried out essentially as described previously (21).
DNA manipulation and molecular cloning were performed
according to Sambrook and Russel (22).
In vitro transposition
In vitro transposition reactions were carried outusingthe MuA
transposase (Finnzymes, Espoo, Finland) following the man-
ufacturer’s instructions. Brieﬂy, the transposon fragment was
released from the plasmid vector by digesting with BglII,
separated from the vector backbone by agarose gel electro-
phoresis and puriﬁed using the Qiaquick Gel Extraction Kit
(Qiagen). Each 20 ml in vitro transposition reaction mixture
contained 1· reaction buffer, 20 ng transposon fragment,
400 ng target DNA and 0.22 mg MuA transposase. The reac-
tion mixture was incubated at 30 C for 1 h followed by 10 min
at 75 C. One microlitre of the reaction mixture was electro-
porated into Escherichia coli DH10B, selecting for resistance
to an antibiotic encoded by the transposon and resistance to
another antibiotic coded for by the target plasmid.
Bacterial medium and antibiotics
Luria–Bertani medium was used for the growth of E.coli cells.
Antibiotics were used at the following concentrations: ampi-
cillin (Amp), 100 mg/ml; chloramphenicol (Cam), 35 mg/ml;
kanamycin (Kan), 15 mg/ml; tetracycline (Tet), 15 mg/ml.
Screening for transposition event by PCR
Bacterial colonies derived from in vitro transposition were
screened by PCR using a primer on the target gene and another
primer located just inside the transposon end with its 30 end
facing outward of the transposon. Three parameters could be
established by this PCR: whether the transposon was located
within an ampliﬁable distance from the primer on the target
gene and, if it was, the approximate location and orientation
of the transposon.
Recombination between two LoxP sites by
Cre recombinase
Recombination was performed by two means. The ﬁrst was to
electroporate the plasmid containing two LoxP sites to an
E.coli strain expressing the Cre recombinase. Plasmid DNA
was then isolated and the recombination event veriﬁed by
PCR, restriction enzyme digestion and/or sequencing. The
second involved the in vitro recombination using puriﬁed
Cre recombinase (Invitrogen) as follows. Each 20 ml reaction
mixture contained 1· reaction buffer, 100 ng plasmid DNA
and 50 ng Cre recombinase. The reaction was incubated at
37 C for 20 min followed by 5 min at 65 C. One microlitre of
the reaction mixture was used to transform E.coli DH5a.
Individual colonies were screened by PCR, restriction enzyme
digestion and/or by sequencing to identify the clones in which
recombination had taken place.
Gene targeting in mouse embryonic stem cells
The targeting construct was linearized with AscI and electro-
porated into Bruce4 ES (embryonic stem) cells (23) selecting
for resistance to G-418 (0.2 mg/ml). Ten days later, individual
colonies were picked, expanded and split into two. One plate
was frozen at  80 C in media supplemented with 10%
dimethyl sulfoxide. The other plate was lysed and the DNA
was extracted and screened by PCR using the Expand Long
Template PCR System (Roche). Clones that gave the expected
sized band were then conﬁrmed at both the 50 and 30 ends by
Southern analysis.
Transposons and BAC clones used in this study
Transposons constructed in this study included: TnCR1 (Gen-
Bank accession no. AY781408); TnCR2 (GenBank accession
no. AY781399); TnCR3 (GenBank accession no. AY781400);
TnCR4 (GenBank accession no. AY781401); TnCR7
(GenBank accession no. AY781405); TnCR8A (GenBank
accession no. AY781406); TnCR8B (GenBank accession no.
AY781407).
BACs used in this study were: RP23-225H9 for emr1,
RP23-77M4 for TWEAK, RP23-351I24 for sperizin gene
and RP23-461K18 for ubiquitin-speciﬁc protease 1 gene.
RESULTS
Construction of mini-Mu-based transposons
For the generation of deletions in cloned genes, three pairs of
mini-Mu transposons were constructed (Figure 1) based on the
transposon end sequence of Haapa et al. (20). The two trans-
posons in each pair carried a different bacterial selectable
marker which enabled selection of transposition events after
transformation. One of the two transposons carried a Neo
r
gene, which could be replaced with any suitable marker.
The two transposons in each pair also carried either a LoxP
siteorcomplementaryrestrictionendonucleasesites(Figure1).
Figure 1. Mini-Mu transposons for the construction of targeting vectors. Each
transposon has one or two antibiotic resistance genes flanked by transposon
ends (filled black squares) with LoxP (open triangle) and/or restriction sites.
PGK, the human PGK promoter; Cam
r, bacterial chloramphenicol resistance
gene; Tet
r, bacterial tetracycline resistance gene; Neo
r, G-418 resistance gene
without a promoter; PGK-Neo
r, G-418 resistance gene driven by the PGK
promoter; P/P-Kan
r/Neo
r, eukaryotic/prokaryotic dual promoters driving the
expression of kanamycin resistance in E.coli and G-418 resistance in mamma-
lian cells.
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Transposon events are generally considered to be random or
nearly random (24) with some exceptions. However, given the
novelty of our approach and the concern that the presence
of extended palindromic sequences (from both the transposon
ends and the LoxP sites), the randomness of the transposition
events was assessed directly. TnCR7 (Figure 1) was used to
test if the transposition was random in both insertion site and
orientation. A plasmid was constructed by replacing the tetra-
cycline resistance gene of pBR322 with a mouse DNA frag-
ment containing the ubiquitin-speciﬁc protease 1 gene. This
plasmid when digested with HindIII produces six fragments of
various sizes. TnCR7 was transposed to this clone by in vitro
transposition and plasmid DNA extracted from 46 randomly
selected colonies was digested with HindIII. As there is no
HindIII site on the transposon, any fragment of the plasmid
which had acquired the transposon would produce a bigger
band when subjected to electrophoresis on agarose gels.
Among the 46 colonies tested, the number of insertions on
each fragment is reported in Table 1.
It can be seen from Table 1 that the frequency of insertions
in any particular HindIII fragment was directly proportional to
the size of the fragment. An exception is the 3322 bp vector
fragment which had less insertion than the smaller fragments.
This was expected because transposon insertions to the ampi-
cillinresistancegeneandtoregionsessentialforplasmidmain-
tenancewouldbeeliminatedundertheexperimentalconditions.
To assess the orientation of the transposition events, 19 inser-
tions on 3 fragments were tested to determine if there was any
bias. This was done by PCR using a primer on the plasmid and
another on the transposon. Table 2 reveals that 10 insertions
were intheforwardorientation and9inthe reverseorientation,
indicatingthatthereisnoorientationalbiasforthetransposition
events.Theseresultsindicatedthatmini-Mu-basedtransposons
insert into plasmidDNA ina randommannerunaffected bythe
presence of the extended palindromic sequences.
Generation of targeting vectors using Pair 1:
TnCR1, TnCR2
TnCR1 contains the PGK promoter and the bacterial
chloramphenicol (Cam
r) gene, separated by a LoxP site
(Figure 1A). TnCR2 carries the bacterial tetracycline resist-
ance gene, followed by a LoxP site and then the Neo
r gene
without a promoter (Figure 1B). This pair of transposons was
used to generate deletions in an 11 kb fragment containing part
of the mouse emr1 gene (25) (Figure 2).
TnCR1 was inserted into the emr1 region by in vitro trans-
position. Among the 95 colonies screened by PCR, four clones
produced PCR products of  500 bp (Table 3). One was selec-
ted and conﬁrmed by DNA sequencing to have TnCR1 inser-
ted 466 bp upstream of exon 1. TnCR2 was inserted to this
cloneand30colonieswere screened byPCR.Twocloneswere
identiﬁed as having the TnCR2 located  2 kb downstream
of exon 1 and in the right orientation. One clone was selected
and shown to have TnCR2  2 kb downstream of exon 1. The
exact location was not determined because the transposon
landed in a region for which the sequence was unavailable
in the public databases. This highlights another advantage of
this transposon-based strategy—the complete genomic
sequence was not required to generate targeting vectors, i.e.
exonic sequence information was sufﬁcient. This clone was
used to generate deletions between the two LoxP sites on the
transposons, by two Cre treatments. First, DNA was electro-
porated into an E.coli strain expressing the Cre recombinase,
Table 1. Randomness of the mini-Mu transposon insertion
Size of the
HindIII fragment
Number of
insertions
7580 bp 21
3322 bp (vector) 5
1430 bp 9
1355 bp 8
1038 bp 2
392 bp 1
Table 2. Random orientation of the mini-Mu transposon insertion
HindIII fragment Orientation 1 Orientation 2
1355 4 4
1038 2 0
1430 4 5
Figure 2. Schematic representation of generating targeting vectors using
TnCR1 and TnCR2. TnCR1 is inserted into the target gene by in vitro
transposition. TnCR2 is then inserted at the other side of the region to be
deleted. Deletions are generated between the two LoxP sites by one of two
Cretreatments.First,DNAiselectroporatedintoanE.colistrainexpressingthe
Cre recombinase. Second, the construct is treated with Cre recombinase
(Invitrogen) and then transformed to E.coli.
Table 3. Generation of deletions in the emr1 gene by TnCR1 and TnCR2
Deletion generated
2.5 kb deletion 4.5 kb deletion
Frequency of ideal TnCR1
position by PCR
4/95 2/95
Frequency of ideal TnCR2
position by PCR
2/30 1/160
Efficiency of recombination
in E.coli expressing Cre
5/5 10/10
Efficiency of recombination
by Cre recombinase
12/18 4/10
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selected were found to be sensitive to chloramphenicol and
tetracycline, indicating that recombination had occurred.
Restriction digestion of plasmid DNA showed digestion
patterns corresponding to recombination between the two
LoxP sites, generating a 2.5 kb deletion. Second, the same
DNA carrying both transposons was treated in vitro using Cre
recombinase, followed by transformation into E.coli with the
selection of ampicillin resistance. Eighteen colonies were
tested and 12 were found to be sensitive to chloramphenicol
and tetracycline. A 2.5 kb deletion was subsequently
conﬁrmed by restriction mapping.
In another experiment also using emr1, 95 colonies were
screened by PCR after transposition with TnCR1 and two
clones produced PCR products of  2 kb. One was selected
and found, by sequencing, to have the transposon 2321 bp
upstream of exon 1. After transposition with TnCR2, 160
colonies were screened by PCR. One clone was identiﬁed
as having the second transposon located  2 kb downstream
of exon 1. This clone was used to generate deletions between
the two LoxP sites on the transposons. After DNA was elec-
troporated into the E.coli strain expressing the Cre recom-
binase, 10 ampicillin-resistant transformants revealed that
they were all sensitive to chloramphenicol and tetracycline.
Restriction digestion of plasmid DNA showed digestion pat-
terns corresponding to recombination between the two LoxP
sites, resulting in a 4.5 kb deletion. The same DNA carrying
both transposons was treated in vitro using Cre recombinase,
followed by transformation into E.coli with the selection of
ampicillin resistance. Ten colonies were tested and four were
found to be sensitive to chloramphenicol and tetracycline. A
4.5 kb deletion was subsequently conﬁrmed by restriction
mapping.
Generation of targeting vectors using
Pair 2: TnCR3, TnCR4
TnCR3 contains the PGK- Neo
r construct and the bacterial
Cam
r gene, the latter being ﬂanked by sequences for three 8-
base cutters: Not1, Pme1 and Pac1 (Figure 1C). TnCR4 carries
the bacterial tetracycline resistance gene ﬂanked by sequences
for the same 8-base cutters (Figure 1D). A plasmid carrying
14.4 kb of mouse genomic DNA containing exons 1–5 of the
TWEAK gene (26) was used to construct targeting vectors
(Figure 3 and Table 4). TnCR3 was inserted into the
TWEAK region by in vitro transposition and from the 96
colonies screened by PCR, three clones produced PCR pro-
ducts of the desirable sizes. Two clones, with the transposon at
854 and 1008 bp upstream of the ATG start codon, respect-
ively, were selected to insert TnCR4. Ninety-six colonies were
screened by PCR with seven clones having TnCR4 located in
the ideal location and orientation. The DNA ofall seven clones
was digested with Pac1 and two of them gave a band of ideal
size to be deleted. The digested DNA of these two clones was
re-ligated and transformed to E.coli selecting for ampicillin
resistance. One colony from each was tested and found to be
sensitive to chloramphenicol and tetracycline. Plasmid DNA
of both clones was sequenced to identify the deletion. Both
deletions started at 1008 bp upstream of the ATG start codon.
Onedeletionendedinsideofexon5andtheotherended188bp
downstream of exon 5.
TnCR3 was also used to generate a targeting vector for the
mousesperizingene (27).Invitro transpositionwascarriedout
to a plasmid containing 11 kb mouse genomic DNA with this
single exon gene. Thirty-two colonies were screened by PCR
and seven generated PCR products of ideal size. Four were
selected and their DNA sequenced. Two out of the four were
found to have the transposon in an ideal position and orienta-
tion. One of them, with the transposon at 1376 bp upstream of
the ATG start codon, was used to generate a targeting vector.
Due to the presence of a Pac1 site 1459 bp downstream of the
TGA stop codon, deletions were generated by digesting the
DNA with Pac1 and re-ligation. Hence, only a single trans-
position event was required to delete the entire sperizin gene.
After transforming to E.coli, 23 transformants tested were all
found to be sensitive to chloramphenicol. One was sequenced
to conﬁrmed the integrity of the deletion.
Generation of conditional targeting vectors using
Pair 3: TnCR7, TnCR8
TnCR7 carries the Cam
r gene ﬂanked by a pair of 8-base
cutters and LoxP (Figure 1E). TnCR8 carries the euka-
ryotic/prokaryotic dual promoter driving the expression of
the Kan
r/Neo
r gene (Figure 1F). Two versions of the dual
promoters were used. TnCR8A contains the human PGK
promoter in front of the prokaryotic kanamycin resistance
gene promoter (derived from Tn5) whereas TnCR8B uses
Table 4. Generation of deletions in the TWEAK gene by TnCR3 and
TnCR4
Frequency of ideal TnCR1
position by PCR
3/96
Frequency of ideal TnCR2
position by PCR
7/96
Frequency of clones with
desirable size of deletion
2/7
Figure 3. Schematic representation of generating targeting vectors using
TnCR3 and TnCR4. TnCR3 is inserted into the target gene by in vitro
transposition. TnCR4 is then inserted at the other side of the region to be
deleted. Deletions are generated by digesting the DNA with one of the
restriction endonucleases followed by ligation and transformation to E.coli.
e24 Nucleic Acids Research, 2005, Vol. 33, No. 3 PAGE 4 OF 7the bacterial bla promoter followed by the viral SV40 pro-
moter. The P/P- Kan
r/Neo
r cassette in TnCR8 is also ﬂanked
by a pair of 8 bp restriction sites and LoxP sites. These two
transposons were speciﬁcally designed to generate conditional
targeting vectors (Figure 4). A conditional targeting vector
contains recombination sites such as LoxP in the introns ﬂank-
ing the exon(s)targeted fordeletion. After a targeted event, the
gene can still function because the position of the LoxP sites is
selected to minimize the impact on gene expression, i.e. a non-
coding region away from splice acceptor sites and regulatory
elements is desirable. Upon expression of a recombinase gene
such as Cre, however, the region between the LoxP sites will
be deleted, resulting in an inactivated gene. TnCR7 should be
ﬁrst inserted at one side of the exon(s) to be deleted. The Cam
r
gene and a copy of the LoxP site can then be deleted either by
Cre-mediated recombination or by restriction digestion fol-
lowed by ligation, leaving one copy of LoxP on the vector.
TnCR8 is then inserted at the other side of the exon(s) to
generate the conditional targeting vector. These transposons
were used to generate conditional targeting vectors for the
mouse ubiquitin-speciﬁc protease 1 gene (Table 5).
A plasmid with 12 kb mouse genomic DNA containing
exons 2–9 of the ubiquitin-speciﬁc protease 1 gene was sub-
jected to in vitro transposition by TnCR7 and 96 colonies were
screened by PCR. Among six positive colonies, ﬁve had the
transposons between 146 and1576 bp upstreamofexon 3.One
clone,with the transposon located in intron2(265 bp upstream
of exon 3), was selected and plasmid DNA electroporated
into the E.coli strain expressing Cre selecting for ampicillin
resistance. Twenty-ﬁve transformants were patched on a Cam
plate and all were found to be sensitive to chloramphenicol,
indicating the deletion of the Cam
r gene betweenthe two LoxP
sites.
One clone was selected and subjected to in vitro transposi-
tion of both TnCR8A and TnCR8B. Forty-eight colonies were
screened by PCR from each transposition experiment and 15
produced products for TnCR8A and 10 for TnCR8B. One
clone with the transposon located in intron 5 was selected
from each transposition as the conditional targeting vector,
with TnCR8A and TnCR8B located 536 and 624 bp down-
stream of exon 5, respectively.
Gene targeting in mouse ES cells using targeting
vectors generated by transposons
The ability of the transposon-generated vectors to target genes
was tested in mouse ES cells. Two of the constructs (one for
spz-1 and the other one for TWEAK) were electroporated into
Bruce4 ES cells, selected with G-418 and 10 days later 480
individual colonies were picked, expanded and split onto two
plates. One plate was frozen down and the other plate was
lysed and DNA extracted. All colonies were screened for
targeting at the 30 end by a PCR assay using a forward
oligo in the Neo
r gene and a reverse oligo external to the
30 arm. Targeting was subsequently conﬁrmed by Southern
analysis at both the 50  and 30  ends. Four and ﬁve correctly
targeted clones were identiﬁed for the two genes, respectively,
representing a targeting efﬁciency of  1% of the neomycin-
resistant clones picked, which was comparable with other
targeting vectors that we have used. This efﬁciency is relat-
ively low because the vectors do not have a negative-selection
marker (such as TK) to eliminate clones resulting from non-
homologous integration events. However, negative-selection
cassettes may be easily incorporated into the vector. These
targeted cells were subsequently used to generate knockout
mice.
DISCUSSION
We have developed procedures to construct targeting vectors
using transposons. Compared with conventional methods for
vector construction, our methods are rapid and technically
simple. Multiple targeting vectors are routinely generated in
 2 weeks. The procedure does not require direct cloning from
genomic fragments and, hence, no restriction enzyme sites are
required on genomic DNA. Furthermore, it is not necessary to
amplify homology arms by PCR, thus eliminating the chance
Figure 4. Schematicrepresentation ofgeneratingconditional targeting vectors
using TnCR7 and TnCR8. TnCR7 is inserted into the target gene by in vitro
transposition. The Cam
r gene is deleted using either Cre or a restriction
endonuclease, leaving a single copy of LoxP. TnCR8 is then inserted at the
other side of the region to be deleted. The construct is now a conditional
targeting vector.
Table 5. Generation of conditional targeting vectors in the ubiquitin-
specific protease 1 gene by TnCR7 and TnCR8
TnCR7
(clones
with PCR
products)
Position in
clone
selected
Efficiency of
deleting Cam
r
by Cre
recombination
Transposon
(clones
with PCR
products)
Position in
clone
selected
6/96 265 bp
before
exon 3
25/25 TnCR8A
(15/48)
536 bp
after exon 5
TnCR8B
(10/48)
624 bp
after exon 5
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efﬁciency (28).
Othervariantsofthe transposonspresented heremay alsobe
generated. For example, the Neo
r gene could be switched from
TnCR2 to TnCR1, to be inserted between the PGK promoter
and LoxP. Furthermore, it would be advantageous to have a
series of transposons carrying different eukaryotic selectable
markers including hygromycin and puromycin resistance.
Although the in vitro transposon system was initially used,
in vivo systems can also be developed where transposition is
achieved by bacterial mating. We have successfully developed
such a system to mutagenize bacterial genes by Tn5 insertion
(7). This can potentially be adapted for the construction of
targeting vectors. This would negate the need for any trans-
formations which would result in further time savings. The
mini-Mu transposons were selected in this study due to their
high efﬁciency of transposition and lack of transposition
immunity, thus allowing two transposons on the same target
molecule (20). Other bacterial transposons may also be used
but may be less ﬂexible than mini-Mu.
The transposon-mediated procedure for generation of dele-
tions will speed up vector construction as soon as a gene is
cloned. In our method, the optimal size for the initial genomic
clone is 10–15 kb. This may be derived directly from a lambda
clone or any other large genomic clone. Two parameters
should be taken into consideration when choosing the frag-
ment size: (i) it should be short to facilitate easy manipulation
and high efﬁciency of transposition to any desired region;
(ii) at the same time, it should be long enough to leave homo-
logous arms of sufﬁcient length after a deletion event. Given
the randomnessofthetransposonevent,targeting a1kbregion
within a 20 kb clone should result in 5% of all clones screened
being positive for the transposon. This efﬁciency would be
reduced by half if a speciﬁc orientation was required. In our
method, the picking of 96 clones for a PCR-based screen
generally resulted in 1–5 clones with the desired transposon
event. Occasionally, lower rates have been observed but this
was easily overcome by either screening moreclonesorselect-
ing a slightly different target for the transposition event.
We have tended to use regions of genes isolated from BAC
(C57BL/6) clones which have either been generated by direct
subcloning or by ET cloning (29,30). We do not use negative
selection but this may easily be incorporated into the overall
strategy, preferably by inserting the initial genomic clone into
a vector carrying a negative-selection cassette (31). The sys-
tem described here has a number of advantages over current
methods. The most signiﬁcant of these is the generic nature
of the transposons which may be used directly without any
requirement for modiﬁcation. Speed and the ability to handle
multiple genes simultaneously are other key advantages.
A number of technologies are currently available that accel-
erate the process of generating knockouts. ET cloning (32) is
probably the most notable technique that has emerged for the
generation of traditional knockout vectors. Compared with the
transposon technology presented here, ET cloning is also rapid
and highly ﬂexible. An advantage that the transposons have
over the ET technology is that the vectors are generic and may
be used on any gene. ET cloning requires long PCRs which
occasionally suffer from sequence-specifc technical difﬁcult-
ies; furthermore, the requirement for relatively long PCR
primers add signiﬁcant cost to the application of the ET
technology. One advantage of the ET system is that the
vectors constructed are precise rather than semi-random. Non-
traditional strategies have recently emerged, which include
indexed vectors (33) and the use of ES cells with a defective
mismatch repair system (34,35). While these new approaches
are able torapidlygenerateknockout cells or animals they lack
the precision of the traditional application of knockout vectors
and as such have a limited application.
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